Phase III Trial Comparing Treatment With Melphalan+Prednisone (MP) With Melphalan+Prednisone+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma.

Trial Profile

Phase III Trial Comparing Treatment With Melphalan+Prednisone (MP) With Melphalan+Prednisone+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Aug 2013

At a glance

  • Drugs Thalidomide (Primary) ; Melphalan; Prednisone
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Aug 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
    • 05 Dec 2009 Initial results from the Turkish Myeloma Study Group were presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
    • 15 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top